Company intelligence / Profile preview
Allergopharma
Reinbek, Schleswig-Holstein, Germanyallergopharma.dermapharm.com ↗
- Ownership
- Private
- Employees
- ~550
- Development stage
- Commercial
01
Overview
Allergopharma is a leader in allergen-specific immunotherapy (AIT) of type 1 allergies, offering diagnostic and therapeutic products in 18-20 countries worldwide.
- Therapeutic areas
- Immunology
- Modalities
- Allergen-specific immunotherapy productshypoallergenic high-dose products (allergoids)
- Industry
- Biotech
02
Drug pipeline
20 assets19 more assets in the full pipeline.
Beyond the preview
Go deeper on Allergopharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Allergopharma.